Expand RNA Menu
RNA MENU

RNA Latest Press Releases

-- December 1, 2025 --

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 6:59 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN PRNewswire 3:20 PM

-- November 22, 2025 --

Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 5:34 AM

-- November 21, 2025 --

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-WTRG, RNA, FIZN, and TCBX PRNewswire 5:30 PM

-- November 19, 2025 --

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44 PRNewswire 9:13 AM

-- November 10, 2025 --

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights PRNewswire 4:05 PM

-- November 7, 2025 --

Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 4:34 PM

-- October 30, 2025 --

Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:23 PM

-- October 28, 2025 --

RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is Fair to Shareholders Globe Newswire 2:42 PM
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders PRNewswire 1:55 PM
RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders Business Wire 6:40 AM

-- October 27, 2025 --

Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA Business Wire 8:05 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avidity Biosciences, Inc. (NASDAQ: RNA) PRNewswire 5:30 PM
HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PRNewswire 1:01 PM

-- October 26, 2025 --

RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS Globe Newswire 6:36 PM
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG PRNewswire 1:08 PM
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline Globe Newswire 1:00 PM

-- October 16, 2025 --

Avidity Biosciences to Participate in Upcoming Investor Conference PRNewswire 9:01 AM

-- October 13, 2025 --

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026 PRNewswire 9:00 AM

-- October 6, 2025 --

Avidity Biosciences to Present Data from EXPLORE44 Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society PRNewswire 9:01 AM

-- September 15, 2025 --

Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares PRNewswire 4:01 PM

-- September 11, 2025 --

Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock PRNewswire 7:56 PM

-- September 10, 2025 --

Avidity Biosciences Announces Proposed Public Offering of Common Stock PRNewswire 4:01 PM
Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44 and EXPLORE44-OLE Phase 1/2 Trial in People Living with DMD44 PRNewswire 7:00 AM

-- August 27, 2025 --

Avidity Biosciences to Participate in Upcoming Investor Conferences PRNewswire 9:00 AM

-- August 7, 2025 --

Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights PRNewswire 4:05 PM
Market Data Delayed 15 Minutes